Results from the first year of a two-year National Institutes of Health (NIH) clinical trial show that Avastin®, a drug approved to treat some cancers and is commonly used off-label to treat age-related macular degeneration (AMD), is as effective as t…
Author: Medical News Today
Lucentis And Avastin Equally Effective For AMD – Avastin Results In More Hospitalizations
Lucentis and Avastin, both made by pharmaceutical company Genentech, were found to be equally effective in treating age-related macular degeneration (AMD). Lucentis is approved for this eye-condition, while Avastin, a cancer medication, is also used of…
Molecular Partners Reports Positive Results From Its First Clinical Studies
Molecular Partners AG, a leader in the development of next generation therapeutics, announced today that it has completed two phase I/IIa clinical trials with MP0112, its lead molecule targeting VEGF-A. The DARPin molecule was shown to be safe and well…
There’s More To Implants Than Meets The Eye
In this month’s Physics World, Richard Taylor, professor of physics, psychology and art at the University of Oregon, warns that artificial retinal implants – a technology fast becoming a reality – must adapt to the unique features of the human eye in o…
Regeneron And Bayer Report Positive Results For VEGF Trap-Eye In Second Phase 3 Study In Central Retinal Vein Occlusion
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare announced positive top-line results for VEGF Trap-Eye (aflibercept ophthalmic solution) in the Phase 3 GALILEO study in patients with macular edema due to central retinal vein occlusio…
Bioengineering Students’ Invention May Help Diagnose Painful Dry Eye
Rice University bioengineering students responded to an ophthalmologist’s cry for help with a device to diagnose dry eye, the itching and burning sensation that results when a person doesn’t produce enough tears or the tears evaporate too quickly…
Mass. Eye And Ear Spotlights Healthy Vision Month
The Massachusetts Eye and Ear Infirmary consistently promotes eye health and regular vision screenings as part of its mission and this month the hospital is highlighting healthy sight during the month of May. May is the Healthy Vision Month, an annual …
University Of Houston’s Highest Honor Received By Renowned Glaucoma Researcher
One of the world’s foremost glaucoma researchers, Ronald S. Harwerth, is the recipient of the 2011 Esther Farfel Award, the highest distinction bestowed upon faculty by the University of Houston (UH). Carrying with it a cash prize of $10,000, the Farfe…
Researcher’s Vaccine Technology For Chlamydia: WSU Files For Patent
A Wayne State University School of Medicine researcher has developed a potential first ever vaccine for Chlamydia, the world’s most prevalent sexually transmitted disease and the leading cause of new cases of blindness. Judith Whittum-Hudson, Ph.D…
Second Sight Medical Products Announces European Market Approval Of A Retinal Prosthesis For The Blind
After more than 20 years of research and development involving a team of international specialists, Second Sight Medical Products, Inc., the leading developer of retinal prostheses for the blind, is pleased to announce that its Argus II Retinal Prosth…
London Eye Hospital Performs World’s First Bifocal Light Adjustable Lens (LAL) Eye Surgery
The London Eye Hospital, the UK’s leading centre for premium lens implants, has today completed the world’s first bi-focal Light Adjustable Lens (LAL) eye surgery, apart from clinical trials. Typically used during cataract or clear lens extraction sur…
ACT Files European Clinical Trial Application For Phase 1/2 Study Using Embryonic Stem Cells To Treat Macular Degeneration
Advanced Cell Technology, Inc…
Promedior Announces Presentation Of Data At ARVO Demonstrating That PRM-151 (rhPTX-2) Suppresses Choroidal And Retinal Neovascularization
Promedior, Inc. today announced that data from preclinical studies of PRM-151 (recombinant human Pentraxin-2 (PTX-2)) will be presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)…
Singapore Eye Research Institute Performs Breakthrough Research On Chronic Inflammatory Eye Conditions With AB SCIEX TripleTOF™ 5600 System
AB SCIEX, a global leader in life science analytical technologies, today announced that the Singapore Eye Research Institute (SERI), an internationally known eye research center, will advance biomarker candidates it identified for chronic inflammatory …
Ophthalmologists Report Significant Changes In Prescribing Among Primary Open Angle Glaucoma Patients As Pfizer’s Xalatan Goes Generic
The impact of the genericization of Pfizer’s Xalatan at the end of March 2011 is reflected in changes to both current and anticipated ophthalmologist prescribing behavior for primary open angle glaucoma (POAG) patients…
Prospects Grow For Blindness Recovery, Australia
Prospects for recovery of lost vision have brightened with the release of new scientific findings showing that the use of gentle near infra-red light can reverse damage caused by exposure to bright light, up to a month after treatment…
Screening Begins For Active Ingredients For The Treatment Of Batten Disease
It is a rare disease with devastating consequences: Around first grade, the children start experiencing vision impairments, which two to three years later progress to complete blindness. This is the first indication of a progressive destruction of brai…
National Innovative Vision Research Award To Be Presented To IUPUI Faculty Member
Jason S. Meyer, Ph.D., assistant professor of biology in the School of Science at Indiana University-Purdue University Indianapolis, will be honored by the largest eye and vision research organization in the world for work which one day may lead to rev…
USC Researchers Develop Gene Therapy With Potential To Restore Sight To The Blind
Researchers at the Keck School of Medicine of the University of Southern California (USC) have developed a potential therapy for blindness that involves delivering a gene encoding a light-sensitive protein to inner retinal cells, enabling photosensitiv…
New Study Finds Eye Exams First To Detect Chronic Diseases
A new study released shows that eye exams are often the first to detect chronic diseases like diabetes and hypertension…